An Immunohistochemical Study to assess the Expression of Estrogen and Progesterone Receptor in Endometrial hyperplasia and Endometrial carcinoma compared to normal Endometrium: A Prospective Pathological Study-Reference-Cited by-同舟云学术

An Immunohistochemical Study to assess the Expression of Estrogen and Progesterone Receptor in Endometrial hyperplasia and Endometrial carcinoma compared to normal Endometrium: A Prospective Pathological Study

Published:2024-02-20 Issue: Volume: Page:491-495
ISSN:0974-360X
Container-title:Research Journal of Pharmacy and Technology
language:en
Short-container-title:RJPT

Author:

Singh Anu¹,Bharati Purnima²,Singh Vinita³,Chowdhary Ratna⁴

Affiliation:

1. Assistant Professor, Department of Pathology, Institute of Medical Sciences BHU, Varanasi, Uttar Pradesh, India.

2. Assistant Professor, Department of Pathology, Sheikh Bhikhari Medical College, Hazaribag, Jharkhand, India.

3. Additional Professor, Department of Obstetrics and Gynaecology, AIIMS Raipur, Chattisgadh, India.

4. Professor, Department of Pathology, RIMS Ranchi, Jharkhand, India.

Abstract

Background: To compare the expression of ER, PR, and Her-2/neu in cases of endometrial hyperplasia and endometrial carcinoma within glands and stroma with normal endometrium. Methods: Samples of formalin-fixed, paraffin-embedded tissue of 62 patients coming to a tertiary care center were immunohistochemically studied for expression of ER and PR. Results: Steroid Hormone receptor levels of both ER and PR were overexpressed in endometrial hyperplasia and carcinoma compared to normal endometrium. However, same was significantly reduced in adenocarcinoma compared to simple hyperplasia and revealed a statistical significance with a p-value <0.05. Conclusions: Immunohistochemical expression of ER and PR should be evaluated in all cases of simple and atypical hyperplasia, and adenocarcinoma as their expression can facilitate a prognostic marker and can entail hormonal therapy in future for such cases.

Publisher

A and V Publications

Reference9 articles.

1. Soper JT, Segreti EM, Novotny DB, Mutch D, Creasman WT, McCarty KS Jr. Estrogen and progesterone receptor content of endometrial carcinomas: comparison of total tissue versus cancer component analysis. Gynecol Oncol. 1990; 36(3):363-8.

2. Vilgelm A, Lian Z, Wang H, Beauparlant SL, Klein-Szanto A, Ellenson LH, Di Cristofano A. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice, Cancer Res. 2006; 66:3375-3380.

3. K S McCarty Jr et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch pathol Lab Med. 1985

4. Nyholm HC, Nielson AL, Lyndrup J, Norup P, Thorpe SM. Biochemical and Immunohistochemical estrogen and progesterone receptors in endometrial hyperplasia and endometrial carcinoma. American Journal of Obstetrics and Gynecology. 1992; 167(5):1334-42.

5. Christine Bergeron, Alex Ferenczy, David O. Toft, and Gopalan Shyamala. Immunocytochemical Study of Progesterone Receptors in Hyperplastic and Neoplastic Endometrial Tissues. Cancer Research. 1988; 48: 6132-6136.